Not everything new is better. An ancient 21 day diet plan from the Bible called the Daniel Fast has been tested at a major university to see if it would improve
US Health and Human Services Secretary Robert F. Kennedy Jr. on Monday dismissed an expert panel of vaccine advisers that has historically guided the federal…
In a public letter, hundreds of scientists expressed their dissent to the Trump administration’s policies affecting the National Institutes of Health and called on its…
Phase 1 trial of AFM13 for CD30+ lymphoma yields 92.9% ORR, 66.7% CR, per Nature study. Explore NK cell therapy results.
AbstractBackgroundPrivate equity firms have rapidly acquired U.S. hospitals and increasingly invested in cardiology over the past decade. However, little is known about how private equity…
Phase 3 VISIONARY trial data presented at the ERA Congress 2025 showed sibeprenlimab helps achieve significant proteinuria reduction in patients with IgA nephropathy (IgAN).
AbstractBackgroundThe ALT-FLOW trial EFS (Early Feasibility Study) evaluated safety, hemodynamics and outcomes for the APTURE system in patients with HF and mildly reduced or preserved…
AbstractBackgroundIn-stent occlusion (ISO) comprises various components, including thrombus and neointimal hyperplasia, but its detailed characteristics and treatment responses remain unclear.Case …
AbstractBackgroundHemodynamically obstructive coronary plaques may contain more vulnerable plaque characteristics than nonobstructive lesions.ObjectivesThe authors aimed to assess whether pressure-…
In this part 2 of a 2-part continuing medical education series, the management, outcomes, and morbidities for fungal skin neglected tropical diseases (NTDs), including eumycetoma,…
